TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/21/24 17:20 | 3/19/24 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Vasista Vittal | MD | O | CFO | M.d | 75 | 3.76 | 0 | 20 | 9 | 247 | D | |||||||||||||||
6/2/23 16:12 | 5/31/23 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Vasista Vittal | MD | O | CFO | M.d | 30 | 0.8500 | 0 | 35 | 19 | 215 | D | |||||||||||||||
8/31/22 18:01 | 8/30/22 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Vasista Vittal | MD | O | CFO | S | -73 | 30.24 | 0 | -2 | -2 | 135 | D | |||||||||||||||
8/8/22 16:04 | 8/4/22 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Vasista Vittal | MD | O | CFO | S.m | -622 | 35.18 | 0 | -18 | -11 | 138 | D | |||||||||||||||
8/3/22 17:26 | 8/1/22 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Vasista Vittal | MD | O | CFO | S | -75 | 31.26 | 0 | -2 | -2 | 155 | D | |||||||||||||||
7/15/22 16:18 | 7/13/22 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Vasista Vittal | MD | O | CFO | S.m | -144 | 30.01 | 0 | -5 | -3 | 158 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |